Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 19 868.9 |
96 | EP file number | EAKZ | 01 30 8806.7 |
97 | EP publication number | EPN | 1199071 |
54 | Designation/title | TI | Verwendung eines Östrogenagonisten zum Verbessern der vaskulären Gesundheit |
51 | IPC main class | ICM (ICMV) | A61K 31/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 9/10 (2006.01), A61P 9/00 (2006.01), A61P 13/12 (2006.01) |
22 | DE application date | DAT | Oct 16, 2001 |
96 | EP application date | EAT | Oct 16, 2001 |
43 | Date of first publication | OT | Apr 24, 2002 |
| Date of publication of grant | PET | May 24, 2006 |
71/73 | Applicant/owner | INH | Pfizer Products Inc., Groton, Conn., US |
72 | Inventor | IN | Day, Wesley W Pfizer Global Research & De, Groton, Connecticut 06340, US; Lee, Andrew G Pfizer Global Research & De, Groton, Connecticut 06340, US; Thompson Pfizer Global Research & Development, D., Groton, Connecticut 06340, US |
74 | Representative | VTR | Kraus & Weisert Patentanwälte PartGmbB, 80539 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000060119868T2 Searchable text:
DE000060119868T2 |
| Address for service | | Kraus & Weisert Patentanwälte PartGmbB, 80539 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 241532 P Oct 17, 2000
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
43 | Date of first publication | EVT | Apr 24, 2002 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 31, 2015 (Show all update days)(Hide all update days)- Mar 31, 2015; Jan 23, 2013
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|